The Optivalue Tek Consulting IPO launched from September 2 to September 4, 2025, aiming to raise ₹51.82 crore through a fresh issue priced between ₹80 and ₹84 per share. Established in 2011, the company specializes in technology consulting services focused on enterprise modernization, digital transformation, and managed IT services. The Optivalue Tek Consulting IPO provides an opportunity to invest in a company riding the wave of technological advancement and increasing digitization of enterprises.
₹15
₹84
₹103.60
Expert Opinions
The Optivalue Tek Consulting IPO has sparked positive market sentiment, highlighting strong investor interest in the technology consulting sector. The company excels with a diversified portfolio, including enterprise modernization, cloud solutions, AI analytics, and telecom OSS/BSS services across 20+ countries. Its strengths include a robust financial base and a proven track record of over 500 successful projects.
For FY 2025, the Optivalue Tek Consulting IPO demonstrated impressive financials with a Return on Equity (ROE) of 38.09%, Return on Capital Employed (ROCE) of 50.26%, and a Net Asset Value (NAV) of ₹9.29, indicating excellent capital efficiency. Risks include high promoter shareholding concentration, competitive industry pressures, and the need for continued innovation. Long-term investors may benefit from the company’s strategic position in a rapidly evolving tech landscape, though they should remain aware of sector risks and market competition.
Investor Considerations
The Optivalue Tek Consulting IPO represents a technology consulting company with strong operational performance and robust fundamentals. The company recorded a significant revenue increase of 54% in FY 2025, reaching ₹56.47 crore, with profit after tax more than doubling to ₹12.14 crore. The sector outlook remains promising given the growing demand for digital transformation and IT modernization globally.
The Optivalue Tek Consulting IPO valuation highlights a Return on Net Worth (RoNW) of 38.09%, a healthy PAT margin of 22%, and a low Debt/Equity ratio of 0.17, showcasing excellent profitability and financial stability. Growth prospects are underpinned by a diversified client base across 20+ countries and leading-edge technology services. Risks include high promoter shareholding concentration, competitive pressures, and rapid technological changes. The IPO suits long-term investors seeking tech sector growth, while short-term investors should consider market volatility and sector dynamics.
| Date | GMP | Trend |
|---|---|---|
| 09 Sep 2025 12.24 | ₹15 | Up |
| 07 Sep 2025 13.27 | ₹8 | Up |
| 06 Sep 2025 10.35 | ₹5 | --- |
| 05 Sep 2025 11.51 | ₹5 | Down |
| 04 Sep 2025 15.37 | ₹10 | --- |
FAQs
The Grey Market Premium showed good accuracy in predicting Amanta Healthcare IPO’s listing performance. With a final GMP of ₹15, it projected a premium of 17.86% over the issue price of ₹84. The stock listed at ₹103.60, delivering a gain of 23.33%. This resulted in a small prediction error of 5.47%, where the GMP correctly signaled a positive listing and slightly underestimated the actual gain, reflecting fair reliability in this case.
Optivalue Tek Consulting IPO Current GMP is ₹15.
Optivalue Tek Consulting IPO Expected Returns is 17.86%.
Optivalue Tek Consulting IPO estimated listing price is ₹99.